Be aware that MBP have already announced that they plan a share issue to be aligned with a NASDAQ listing.
What price the issue?
And will the timing coincide or be close to their up-coming, eagerly awaited, well publicised soon to be announcement on the results of their phase 2b trials?
Any price movement could be a flash, then trading halt, then shares at discounts.
Getting risky.
Although it should be nice to get some before it finally takes off when a big pharma deal gets done.
Regards.
TDF
- Forums
- ASX - By Stock
- MBP
- worth a punt @ $1.60
worth a punt @ $1.60, page-5
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)